Related Experiment Video
Updated: Jun 20, 2026
07:12
Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
Published on: August 17, 2022
Renal secondary hyperparathyroidism in dogs
Jenefer R Stillion1, Michelle G Ritt
1Cornell University Hospital for Animals, NY, USA.
Compendium (Yardley, PA)
|September 12, 2009
Summary
Chronic renal failure in dogs can cause secondary hyperparathyroidism, altering calcium and phosphorus levels. This condition, marked by increased parathyroid hormone (PTH), leads to serious health issues, with a guarded prognosis despite treatments.
Area of Science:
- Veterinary Medicine
- Endocrinology
- Nephrology
Background:
- Parathyroid hormone (PTH) regulates calcium homeostasis.
- Chronic renal failure (CRF) in dogs can lead to secondary hyperparathyroidism.
- This condition significantly disrupts calcium and phosphorus metabolism.
Purpose of the Study:
- To describe the pathophysiology of renal secondary hyperparathyroidism in dogs.
- To outline the clinical and metabolic alterations associated with this syndrome.
- To discuss potential therapeutic strategies and their impact on prognosis.
Main Methods:
- Review of existing literature on canine secondary hyperparathyroidism.
- Analysis of the interplay between chronic renal failure, calcium, phosphorus, PTH, and calcitriol.
- Evaluation of the effects of increased PTH levels on various organ systems.
Main Results:
- Renal secondary hyperparathyroidism involves complex changes in calcium, phosphorus, PTH, and calcitriol.
- Elevated PTH levels contribute to soft tissue mineralization, fibrous osteodystrophy, bone marrow suppression, urolithiasis, and neuropathy.
- Therapeutic interventions like dietary phosphorus restriction, phosphate binders, and calcitriol supplementation aim to manage PTH levels and slow disease progression.
Conclusions:
- Renal secondary hyperparathyroidism is a serious complication of chronic renal failure in dogs.
- While treatments can help manage PTH concentrations, the overall prognosis remains guarded to poor.
- Further research may be needed to improve outcomes for affected animals.
More Related Videos
Related Concept Videos
00:59The Parathyroid Glands
The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:23Hypothyroidism II: Pathophysiology
Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
01:17Hormones and Bone Tissue
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...